Market Cap

Arch Biopartners, Inc. Market Capitalization:

C$115.3 Million

CAD as of July 1, 2025

US$84.5 Million

business Arch Biopartners, Inc. Company Profile

Arch Biopartners, Inc. Main Stock Listing

TSXV: ARCH

Market Capitalization History of Arch Biopartners, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Arch Biopartners, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 C$120.6 M 33.49%
Jan. 1, 2024 C$90.4 M -49.31%
Jan. 1, 2023 C$178.3 M -13.33%
Jan. 1, 2022 C$205.7 M 157.81%
Jan. 1, 2021 C$79.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Arch Biopartners, Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Arch Biopartners, Inc. has the following listings and related stock indices.


Stock: TSXV: ARCH

Stock: OTC: ACHFF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.